MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #JPMorganconference–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time.
The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
SOURCE: Hologic, Inc.
Contacts
Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com
BARCELONA, Spain, June 24, 2024 /PRNewswire/ -- Aetion®, the global leader in real-world evidence (RWE)…
NEW YORK, June 24, 2024 /PRNewswire/ -- The global wearable patch market size is estimated to grow…
NEW YORK, June 24, 2024 /PRNewswire/ -- The global rehabilitation robots market size is estimated to…
Mississauga, Ontario--(Newsfile Corp. - June 24, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the…
SUN PRAIRIE, Wis., June 24, 2024 /PRNewswire/ -- Independent Pharmacy Cooperative (IPC), a leading group…
WASHINGTON, June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its…
